Europe Veterinary Vaccines Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Vaccine Type (Livestock Vaccines [Bovine Vaccines and Small Ruminant Vaccines], Companion Animal Vaccines [Feline Vaccines, Canine Vaccines, and Others], and Others) and Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, and Others)

No. of Pages: 132    |    Report Code: TIPRE00027166    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Veterinary Vaccines Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Veterinary Vaccines Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Veterinary Vaccines Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing pet population
  • 5.1.2 Growing awareness of animal health
5.2 Market Opportunities
  • 5.2.1 Growth in pet healthcare
  • 5.2.2 Expansion in companion animal vaccines
5.3 Future Trends
  • 5.3.1 Growth in animal vaccination programs
  • 5.3.2 Development of advanced veterinary therapeutics
5.4 Impact of Drivers and Restraints

6. Europe Veterinary Vaccines Market Regional Analysis

6.1 Europe Veterinary Vaccines Market Overview
6.2 Europe Veterinary Vaccines Market Revenue 2019-2028 (US$ Million)
6.3 Europe Veterinary Vaccines Market Forecast Analysis

7. Europe Veterinary Vaccines Market Analysis – by Vaccine Type

7.1 Livestock Vaccines
  • 7.1.1 Overview
  • 7.1.2 Livestock Vaccines: Europe Veterinary Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Companion Animal Vaccines
  • 7.2.1 Overview
  • 7.2.2 Companion Animal Vaccines: Europe Veterinary Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Veterinary Vaccines Market Analysis – by Technology

8.1 Live Attenuated Vaccines
  • 8.1.1 Overview
  • 8.1.2 Live Attenuated Vaccines: Europe Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Inactivated Vaccines
  • 8.2.1 Overview
  • 8.2.2 Inactivated Vaccines: Europe Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Toxoid Vaccines
  • 8.3.1 Overview
  • 8.3.2 Toxoid Vaccines: Europe Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Recombinant Vaccines
  • 8.4.1 Overview
  • 8.4.2 Recombinant Vaccines: Europe Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Conjugate Vaccines
  • 8.5.1 Overview
  • 8.5.2 Conjugate Vaccines: Europe Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Veterinary Vaccines Market – Europe Analysis

9.1 Europe
  • 9.1.1 Europe Veterinary Vaccines Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 9.1.1.1 Europe Veterinary Vaccines Market – Revenue and Forecast Analysis – by Country
  • 9.1.1.1 UK: Europe Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.1.1 UK: Europe Veterinary Vaccines Market Breakdown, by Vaccine Type
    • 9.1.1.1.2 UK: Europe Veterinary Vaccines Market Breakdown, by Technology
  • 9.1.1.2 Germany: Europe Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.2.1 Germany: Europe Veterinary Vaccines Market Breakdown, by Vaccine Type
    • 9.1.1.2.2 Germany: Europe Veterinary Vaccines Market Breakdown, by Technology
  • 9.1.1.3 France: Europe Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.3.1 France: Europe Veterinary Vaccines Market Breakdown, by Vaccine Type
    • 9.1.1.3.2 France: Europe Veterinary Vaccines Market Breakdown, by Technology
  • 9.1.1.4 Russia: Europe Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.4.1 Russia: Europe Veterinary Vaccines Market Breakdown, by Vaccine Type
    • 9.1.1.4.2 Russia: Europe Veterinary Vaccines Market Breakdown, by Technology
  • 9.1.1.5 Italy: Europe Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.5.1 Italy: Europe Veterinary Vaccines Market Breakdown, by Vaccine Type
    • 9.1.1.5.2 Italy: Europe Veterinary Vaccines Market Breakdown, by Technology
  • 9.1.1.6 Rest of Europe: Europe Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.6.1 Rest of Europe: Europe Veterinary Vaccines Market Breakdown, by Vaccine Type
    • 9.1.1.6.2 Rest of Europe: Europe Veterinary Vaccines Market Breakdown, by Technology

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. Europe Veterinary Vaccines Market Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 BIOVAC
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 Boehringer Ingelheim International GmbH
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 Ceva
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 Elanco
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 Hester Biosciences Limited
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 HIPRA
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 Merck & Co., Inc.
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 NEOGEN Corporation
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
12.9 Virbac
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
12.10 Zoetis Inc.
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments

13. Appendix

13.1 About Business Market Insights

The List of Companies - Europe Veterinary Vaccines Market

  1. BIOVAC
  2. Boehringer Ingelheim International GmbH
  3. Ceva
  4. Elanco
  5. Hester Biosciences Limited
  6. HIPRA
  7. Merck & Co., Inc. 
  8. NEOGEN Corporation
  9. Virbac
  10. Zoetis Inc.
europe-veterinary-vaccines-market